Safety Alerts & Recalls
Over 50,000 Bottles of Cholesterol Drug Recalled
Micro Labs announced a voluntary recall of 54,096 bottles of Simvastatin Tablets due to failed impurities/degradation specifications.
Mold Discovered in Lactated Ringer's Solution
Hospira has announced a voluntary recall of one lot of Lactated Ringer's Irrigation 3000mL following a confirmed customer report of several dark, fibrous particulate floating within the solution of the primary container.
Multiple Undeclared Drugs Found in Sex Enhancement Pills
The Food and Drug Administration (FDA) is warning consumers to not buy or use Diablos Eca Fire Caps, Stiff Nights, La Pepa Negra, and Herb Viagra, which are marketed for sexual enhancement.
FDA Analysis Reveals More Tainted Weight Loss Pills
The FDA is warning consumers to not buy or use Black Mamba Hyperrush, Lean Body Extreme, and Natural Max Slimming weight loss supplements.
UltraZx Labs Recalls Tainted Weight Loss Caps
UltraZx Labs announced a voluntary recall of all lots of UltraZx, dietary supplements promoted for weight loss, due to the presence of undeclared ingredients.
FDA Warns of Treanda Solution and CSTD Incompatibility
The Food and Drug Administration (FDA) is warning healthcare professionals to not use Treanda (bendamustine HCl solution; Teva) Injection 45mg/0.5mL or 180mg/2mL with closed system transfer devices (CSTD), adapters, and syringes containing polycarbonate or acrylonitrile-butadiene-styrene (ABS).
FDA Issues New Warnings for Chantix
The Food and Drug Administration (FDA) has announced that the labeling for varenicline (Chantix; Pfizer) has been updated to include information on changes to alcohol tolerance and risk of seizures associated with use of the drug.
Hospira Recalls Magnesium Sulfate Injection with Incorrect Barcode
Hospira has announced a voluntary recall of one lot of Magnesium Sulfate in 5% Dextrose 10mg/mL Injection after confirmed customer reports of an incorrect barcode on the primary bag labeling.
Human Hair in Sodium Chloride Container Prompts Recall
Hospira announced a voluntary nationwide recall of one lot of 0.9% Sodium Chloride Injection VisIV flex container following a confirmed customer report of particulate in a single unit.
Update on Duodenoscope Superbug Outbreak for Healthcare Providers
The Food and Drug Administration (FDA) has released updated information for healthcare providers regarding endoscopic retrograde cholangiopancreatography (ERCP) endoscopes (duodenoscopes) following recent adverse event reports of multidrug-resistant bacterial infections in patients who have undergone ERCP with reprocessed duodenoscopes.
MPR Articles
- New Review of Fibromyalgia Treatments in Adult Subgroups
- Over 50,000 Bottles of Cholesterol Drug Recalled
- How Much Zinc Is Needed to Cut Cold Duration, Symptoms?
- Poll: Are You OK With Patients Recording Your Conversations?
- Cholesterol-Lowering Effects of Atorvastatin May Be Greater in Some More Than Others
- Two Older Antibiotics Effective Against Community-Acquired MRSA, Says New Research
- Over 50,000 Bottles of Cholesterol Drug Recalled
- Don't Rely on OTC Homeopathic Asthma Products, Warns FDA
- Rapid Blood Test Could Help Differentiate Bacterial vs. Viral Infection
- Have You Recommended a Pertussis Booster Recently?